Microfluidics Engineering Towards Personalized Oncology-a Review

Overview

Journal In Vitro Model

Date 2025 Jan 28

PMID 39871996

Authors

Sushmita Mishra

Murali Kumarasamy

Affiliations

Soon will be listed here.

Abstract

Identifying and monitoring the presence of cancer metastasis and highlighting inter-and intratumoral heterogeneity is a central tenet of targeted precision oncology medicine (POM). This process of relocation of cancer cells is often referred to as the missing link between a tumor and metastasis. In recent years, microfluidic technologies have been developed to isolate a plethora of different biomarkers, such as circulating tumor cells (CTCs), tumor-derived vesicles (exosomes), or cell/free nucleic acids and proteins directly from patients' blood samples. With the advent of microfluidic developments, minimally invasive and quantitative assessment of different tumors is becoming a reality. This short review article will touch briefly on how microfluidics at early-stage achievements can be combined or developed with the active vs passive microfluidic technologies, depending on whether they utilize external fields and forces (active) or just microchannel geometry and inherent fluid forces (passive) from the market to precision oncology research and our future prospectives in terms of the emergence of ultralow cost and rapid prototyping of microfluidics in precision oncology.

References

Hao S, Wan Y, Xia Y, Zou X, Zheng S . Size-based separation methods of circulating tumor cells. Adv Drug Deliv Rev. 2018; 125:3-20. DOI: 10.1016/j.addr.2018.01.002. View

Lin C, Hsiao Y, Chang H, Yeh C, He C, Salm E . A microfluidic dual-well device for high-throughput single-cell capture and culture. Lab Chip. 2015; 15(14):2928-38. DOI: 10.1039/c5lc00541h. View

Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

Fang S, Tian H, Li X, Jin D, Li X, Kong J . Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS One. 2017; 12(4):e0175050. PMC: 5378374. DOI: 10.1371/journal.pone.0175050. View

Heitzer E, Perakis S, Geigl J, Speicher M . The potential of liquid biopsies for the early detection of cancer. NPJ Precis Oncol. 2018; 1(1):36. PMC: 5871864. DOI: 10.1038/s41698-017-0039-5. View

Sarioglu A, Aceto N, Kojic N, Donaldson M, Zeinali M, Hamza B . A microfluidic device for label-free, physical capture of circulating tumor cell clusters. Nat Methods. 2015; 12(7):685-91. PMC: 4490017. DOI: 10.1038/nmeth.3404. View

Sharma S, Zhuang R, Long M, Pavlovic M, Kang Y, Ilyas A . Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. 2018; 36(4):1063-1078. PMC: 5971144. DOI: 10.1016/j.biotechadv.2018.03.007. View

Pekin D, Skhiri Y, Baret J, Le Corre D, Mazutis L, Salem C . Quantitative and sensitive detection of rare mutations using droplet-based microfluidics. Lab Chip. 2011; 11(13):2156-66. DOI: 10.1039/c1lc20128j. View

Lin H, Chang J, Lin S, Lee M, Huang S, Hsu L . Identification of an In Vivo MEK/WOX1 Complex as a Master Switch for Apoptosis in T Cell Leukemia. Genes Cancer. 2011; 2(5):550-62. PMC: 3161421. DOI: 10.1177/1947601911418498. View

10.

Gascoyne P, Shim S . Isolation of circulating tumor cells by dielectrophoresis. Cancers (Basel). 2014; 6(1):545-79. PMC: 3980488. DOI: 10.3390/cancers6010545. View

11.

Lambein K, Van Bockstal M, Denys H, Libbrecht L . 2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 testing: impact on immunohistochemistry-negative breast cancers. J Clin Oncol. 2014; 32(17):1856-7. DOI: 10.1200/JCO.2013.54.2530. View

12.

Iwai K, Shih K, Lin X, Brubaker T, Sochol R, Lin L . Finger-powered microfluidic systems using multilayer soft lithography and injection molding processes. Lab Chip. 2014; 14(19):3790-9. DOI: 10.1039/c4lc00500g. View

13.

Christodoulou E, Yellapantula V, OHalloran K, Xu L, Berry J, Cotter J . Combined low-pass whole genome and targeted sequencing in liquid biopsies for pediatric solid tumors. NPJ Precis Oncol. 2023; 7(1):21. PMC: 9941464. DOI: 10.1038/s41698-023-00357-0. View

14.

Chen W, Allen S, Reka A, Qian W, Han S, Zhao J . Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics. BMC Cancer. 2016; 16:614. PMC: 4977622. DOI: 10.1186/s12885-016-2638-x. View

15.

OShannessy D, Davis D, Anderes K, Somers E . Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha. Biomark Insights. 2016; 11:7-18. PMC: 4737520. DOI: 10.4137/BMI.S35075. View

16.

Ferraro D, Champ J, Teste B, Serra M, Malaquin L, Viovy J . Microfluidic platform combining droplets and magnetic tweezers: application to HER2 expression in cancer diagnosis. Sci Rep. 2016; 6:25540. PMC: 4860594. DOI: 10.1038/srep25540. View

17.

Pinzani P, DArgenio V, Del Re M, Pellegrini C, Cucchiara F, Salvianti F . Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors. Clin Chem Lab Med. 2021; 59(7):1181-1200. DOI: 10.1515/cclm-2020-1685. View

18.

Huot J, Pin F, Essex A, Bonetto A . MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer. Int J Mol Sci. 2021; 22(3). PMC: 7867345. DOI: 10.3390/ijms22031486. View

19.

Wu M, Ouyang Y, Wang Z, Zhang R, Huang P, Chen C . Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci U S A. 2017; 114(40):10584-10589. PMC: 5635903. DOI: 10.1073/pnas.1709210114. View

20.

Dou M, Mireles Garcia Jr J, Zhan S, Li X . Interfacial nano-biosensing in microfluidic droplets for high-sensitivity detection of low-solubility molecules. Chem Commun (Camb). 2016; 52(17):3470-3. PMC: 4760840. DOI: 10.1039/c5cc09066k. View